Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

From diagnosis to therapy in Duchenne muscular dystrophy.

Journal article

Babbs A. et al, (2020), Biochem Soc Trans

The Long Journey from Diagnosis to Therapy.

Journal article

Davies KE., (2020), Annu Rev Genomics Hum Genet

Surrogate gene therapy for muscular dystrophy.

Journal article

Davies KE. and Chamberlain JS., (2019), Nat Med, 25, 1473 - 1474

Regenerative biomarkers for Duchenne muscular dystrophy

Journal article

Guiraud S. and Davies KE., (2019), Neural Regeneration Research, 14, 1317 - 1320

Limitations to adaptive homeostasis in an hyperoxia-induced model of accelerated ageing.

Journal article

Pomatto LCD. et al, (2019), Redox Biol, 24

Micro-dystrophin Genes Bring Hope of an Effective Therapy for Duchenne Muscular Dystrophy.

Journal article

Davies KE. and Guiraud S., (2019), Mol Ther, 27, 486 - 488

Embryonic myosin is a regeneration marker to monitor utrophin-based therapies for DMD.

Journal article

Guiraud S. et al, (2019), Hum Mol Genet, 28, 307 - 319

Micro-utrophin Improves Cardiac and Skeletal Muscle Function of Severely Affected D2/mdx Mice.

Journal article

Kennedy TL. et al, (2018), Mol Ther Methods Clin Dev, 11, 92 - 105

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle.

Journal article

Kennedy TL. et al, (2017), Skelet Muscle, 7

The protective function of the oxidation resistance 1 gene in ALS

Conference paper

Williamson MG. et al, (2017), GENETICS RESEARCH, 99

Pharmacological advances for treatment in Duchenne muscular dystrophy.

Journal article

Guiraud S. and Davies KE., (2017), Curr Opin Pharmacol, 34, 36 - 48

Load More